The endogenous cannabinoids and cognitive functions in patients with obesity
Aim. To see the association between cognitive function and activity of the endocannabinoid system in patients with obesity. Material and methods. 32 patients (18 female and 14 men) (mean age 47.81 ± 2.34) have been examined. All participants underwent neuropsychological testing, cognitive evoked potential and level of the endocannabinoids measures. Results. It has been shown that cognitive dysfunction has been revealed in patients of middle age with obesity. Activation of the endocannabinoid system was associated with cognitive deficiency in this group.
About Authors (Correspondence):
Zueva I.B. – candidate of medical sciences, head of cardiology department № 1 for patients with myocardial infarction, e-mail: firstname.lastname@example.org
Vanaeva K.I. – doctor of cardiology department № 1 for patients with myocardial infarction, e-mail: email@example.com